Pediatric rhabdomyosarcoma incidence and survival in the United States: An assessment of 5656 cases, 2001–2017
Cancer Medicine · 2023-02 · 12 (3) · 3644-3656
DOI: 10.1002/cam4.5211 ↗Kurz gefasst
Fachartikel in der Zeitschrift Cancer Medicine, online erschienen am 07.09.2022. Verfasst von Matthew T McEvoy und 6 weiteren Autor:innen. Beteiligte Einrichtung: Texas Children's Cancer Center, Baylor College of Medicine, Houston, Texas, USA. Hauptthemen laut MEDLINE: Rhabdomyosarcoma, Rhabdomyosarcoma, Embryonal. Die Arbeit wurde bisher 53-mal zitiert (Crossref) und nennt 53 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Background While rhabdomyosarcoma (RMS) is the most common soft tissue sarcoma in children and adolescents, past epidemiology studies of this malignancy used data that covered
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Texas Children's Cancer Center, Baylor College of Medicine, Houston, Texas, USA.
- Division of Cancer Prevention and Control, Centers for Disease Control and Prevention, Atlanta, Georgia, USA.
- CyberData Technologies, Inc., Herndon, Virginia, USA.
ORCID-Profile: Matthew T McEvoy, David A Siegel, Philip J Lupo
Zitieren
APA
McEvoy, M. T., Siegel, D. A., Dai, S., Okcu, M. F., Zobeck, M., Venkatramani, R., & Lupo, P. J. (2023). Pediatric rhabdomyosarcoma incidence and survival in the United States: An assessment of 5656 cases, 2001–2017. Cancer Medicine, 12(3), 3644-3656. https://doi.org/10.1002/cam4.5211
Vancouver
McEvoy MT, Siegel DA, Dai S, Okcu MF, Zobeck M, Venkatramani R, et al. Pediatric rhabdomyosarcoma incidence and survival in the United States: An assessment of 5656 cases, 2001–2017. Cancer Medicine. 2023;12(3):3644-3656. doi:10.1002/cam4.5211
BibTeX
@article{McEvoy2023,
author = {McEvoy, Matthew T and Siegel, David A and Dai, Shifan and Okcu, Mehmet Fatih and Zobeck, Mark and Venkatramani, Rajkumar and Lupo, Philip J},
title = {Pediatric rhabdomyosarcoma incidence and survival in the United States: An assessment of 5656 cases, 2001–2017},
journal = {Cancer Medicine},
year = {2023},
volume = {12},
number = {3},
pages = {3644--3656},
doi = {10.1002/cam4.5211}
}
EUVIMED